[Notice!!]

ID:
PW:

 

    

    

 

 

  


[2025/06/25]

Manuscript Accepted !!
³í¹®Á¦¸ñ: The role of ubiquitin-proteasome system in preeclampsia

Àú³Î: Molecular Medicine Reports (2024 Impact factor: 3.5)
[2025/06/11]

±¹³»Æ¯Çã 5°Ç µî·Ï ~
¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇöµÇ´Â Å»À¯ºñÄûƾȭ È¿¼ÒÀÇ °ËÃâ¹æ¹ý

Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122809
µî·Ï¹øÈ£: 10-2818565

¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ Àú¹ßÇöµÇ´Â Å»À¯ºñÄûƾȭ È¿¼ÒÀÇ °ËÃâ¹æ¹ý

Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122812
µî·Ï¹øÈ£: 10-2818568

¹ß¸íÀÇ ¸íĪ: ´ëÀå¾Ï ¼¼Æ÷¿¡¼­ Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇö ¶Ç´Â Àú¹ßÇöµÇ´Â Å»À¯ºñÄûƾȭ È¿¼ÒÀÇ °ËÃâ¹æ¹ý

Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122822
µî·Ï¹øÈ£: 10-2818569

¹ß¸íÀÇ ¸íĪ: ´ëÀå¾Ï ¼¼Æ÷¿¡¼­ Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ Àú¹ßÇöµÇ´Â Å»À¯ºñÄûƾȭ È¿¼ÒÀÇ °ËÃâ¹æ¹ý

Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122836
µî·Ï¹øÈ£: 10-2818573

¹ß¸íÀÇ ¸íĪ: Ç¥Àû ´Ü¹éÁú¿¡ ÀÇÇØ °ú¹ßÇöµÇ´Â Å»À¯ºñÄûƾȭ È¿¼ÒÀÇ °ËÃâÀ» À§ÇÑ ´ÙÁß ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ¿ë ÇÁ¶óÀÌ¸Ó ¼¼Æ®

Ãâ¿øÀÏ: 2024.09.10
µî·ÏÀÏ: 2025.06.04
Ãâ¿ø¹øÈ£: 10-2024-0122838
µî·Ï¹øÈ£: 10-2818578
[2025/06/03]

Manuscript Accepted !!
³í¹®Á¦¸ñ: Regulation of Botulinum neurotoxin half-life through the ubiquitin-proteasome system

Àú³Î: Molecular Medicine Reports (2023 Impact factor: 3.4)
[2025/03/12]

ºê¸¯ÀÇ ÇѺû»ç ³í¹® µîÀç
Áø¼±±Ô ³í¹®ÀÌ ÇѺû»ç ³í¹®¿¡ µîÀç

http://www.ibric.org/bric/hanbitsa/treatise.do?mode=treatise-view&id=96415&authorId=32239&pager.offset=0&pagerLimit=10#!/list
[2025/03/04]

Manuscript Accepted !!
³í¹®Á¦¸ñ: Unraveling the Role of Deubiquitinating Enzymes on Cisplatin Resistance in Several Cancers  

Àú³Î: BBA - Reviews on Cancer (2023 Impact factor: 9.7)
1 [2][3][4][5][6][7][8][9][10]..[44] >>
Copyright 1999-2025 Zeroboard / skin by ZINA